Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

RedChip Companies will air interviews with Nova Minerals Limited and Soligenix Inc. on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 21, ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Peratech, which has operations in North Yorkshire and County Durham as well as China and Sweden, has completed a second major ...

The European stock markets closed lower in Friday trading as the FTSE in London was down 1.19%, Germany's DAX slipped 1.49%, France's CAC lost 1.51%, the Stoxx Europe 600 fell 1.42% and the Swiss ...

A letter from the FDA rejecting Merck Sharpe & Dohme Corp.'s proposed label warning that its osteoporosis drug Fosamax could cause stress fractures doesn’t preempt state law claims alleging the ...

Precursor for Semiconductor Market is Segmented by Type (Silicon Precursor, Metal Precursor, High-k Precursor, Low-k ...

Wall Street stocks were in the red early on Friday following yesterday's rally. As of 1520 BST, the Dow Jones Industrial ...

Aligos Therapeutics (Nasdaq: ALGS) has announced positive top-line results from the Phase IIa HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction ...